The American Gastroenterological Association has issued new guidance for patients taking the popular diabetes and weight loss medications glucagon-like peptide 1 receptor agonists, known by brand names including Ozempic and Trulicity, prior to endoscopy.
AGA issues guidance on weight loss drug usage prior to endoscopy
